Keywords: pipex, starts, dosing, patients, ph, ii/iii, trimesta

Pipex starts dosing patients in Ph II/III Trimesta trial

Article | 23 July 2007

Print This

The USA's Pipex Pharmaceuticals has started dosing patients in a multicenter Phase II/III clinical trial for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in